Back to search
Clostridium Difficile-associated Diarrhea (CDAD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Clostridium Difficile-associated Diarrhea (CDAD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Clostridium Difficile-associated Diarrhea (CDAD) trials you may qualify forPrimary Objective: Explore the efficacy of teicoplanin (100-200 mg administered orally twice a day for 7 to 14 days) in patients with Clostridium difficile inf…
Cadazolid has demonstrated activity against a bacteria named Clostridium difficile in animal studies. The results of a first study conducted in adult patients h…
This clinical study is conducted to assess the efficacy of cadazolid compared to vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).